|
70
|
243
|
5l69F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
65
|
240
|
5lajC |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
62
|
220
|
5lf6H |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
62
|
222
|
5l5hL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
59
|
196
|
5laiN |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
59
|
195
|
5l5iJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
60
|
196
|
5l6aN |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
68
|
230
|
5leyA |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
65
|
211
|
5l5vK |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
202
|
5le5N |
Native human 20s proteasome at 1.8 angstrom |
|
71
|
240
|
5laiC |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
65
|
231
|
5laiE |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
57
|
202
|
5lf7N |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
59
|
196
|
5bxnN |
Yeast 20s proteasome beta2-g170a mutant in complex with bortezomib |
|
57
|
196
|
5l68N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
64
|
234
|
5lf3E |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
63
|
231
|
5l6bE |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
61
|
195
|
5lajJ |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
58
|
202
|
5lf0N |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
108
|
309
|
4z67A |
The 1.5-angstrom crystal structure of mn(2+)-bound pqqb from pseudomonas putida |
|
66
|
250
|
5l5hA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
66
|
233
|
5l66M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
105
|
317
|
5c1vA |
Crystal structure analysis of catalytic subunit of human calcineurin |
|
61
|
222
|
5l5vL |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
75
|
212
|
5l55K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
59
|
196
|
5l65N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
64
|
244
|
5lexG |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
64
|
241
|
5l52G |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
57
|
204
|
5l54I |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
67
|
233
|
5l5oM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
222
|
5lcfA |
Vim-2 metallo-beta-lactamase in complex with 3-oxo-2-phenylisoindoline-4-carboxylic acid (compound 30) |
|
63
|
231
|
5l52E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
71
|
240
|
5l65C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
250
|
5laiA |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
62
|
211
|
5l5oK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
243
|
5l5zF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
242
|
5l5vD |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
228
|
5lajM |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
56
|
204
|
5lf3I |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
58
|
204
|
5l5oI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
233
|
5l69M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
70
|
233
|
5laiM |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
234
|
5lf1E |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
63
|
231
|
5lttE |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
67
|
242
|
5l5zD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
231
|
5l68E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
63
|
241
|
5l5dG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
195
|
5l66J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
211
|
5l63K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
68
|
213
|
5le5L |
Native human 20s proteasome at 1.8 angstrom |
